Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Marchand, Kirsten I ^a   Oviedo Joekes, Eugenia ^a,b   Guh, Daphne ^a   Brissette, Suzanne ^c   Marsh, David C ^b,d,e   Schechter, Martin T ^a,b  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF VICTORIA   (Canada)

^e NORTHERN ONTARIO SCHOOL OF MEDICINE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIAMORPHINE; METHADONE; NARCOTIC ANALGESIC AGENT;

ADULT; ARTICLE; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MALE; OPIATE ADDICTION; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SUBCUTANEOUS DRUG ADMINISTRATION;

ADULT; ANALGESICS, OPIOID; CANADA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEROIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; METHADONE; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SATISFACTION; QUESTIONNAIRES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79960659022     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-174     Document Type: Article

References (59)

1. The Cost of Inaction on Hiv Transmission Among Injection Drug Users and the Potential for Effective Interventions. Kuyper LM, Hogg RS, Montaner JSG, Schechter MT, Wood E, J Urban Health 2004 81 655 660 15466846 (Pubitemid 39457947)
2. Substitution treatment of injecting opioid users for prevention of HIV infection. Gowing L, Farrell M, Bornemann R, Sullivan L, Ali R, Cochrane Database Syst Rev 2008 D004145
3. Role of maintenance treatment in opioid dependence. Ward J, Hall W, Mattick RP, Lancet 1999 353 221 6 10.1016/S0140-6736(98)05356-2 9923893 (Pubitemid 29088045)
4. Evidenced-based treatment of opioid-dependent patients. Van den Brink W, Haasen C, Can J Psychiatry 2006 51 635 46 17052031
5. The effects of psychosocial services in substance abuse treatment. McLellan AT, Arndt IO, Metzger DS, Woody GE, O'Brien CP, JAMA 1993 269 1953 9 10.1001/jama.269.15.1953 8385230 (Pubitemid 23106867)
6. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. Amato L, Davoli M, A Perucci C, Ferri M, Faggiano F, P Mattick R, J Subst Abuse Treat 2005 28 321 9 10.1016/j.jsat.2005.02.007 15925266 (Pubitemid 40733141)
7. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Mattick RP, Breen C, Kimber J, Davoli M, Cochrane Database Syst Rev 2009 D002209
8. Does retention matter? Treatment duration and improvement in drug use. Zhang Z, Friedmann PD, Gerstein DR, Addiction 2003 98 673 84 10.1046/j.1360-0443.2003.00354.x 12751985 (Pubitemid 36638206)
9. Best practices in methadone maintenance treatment. Health Canada, Ontario, Canada.: Minister of Public Works and Government Services Canada 2002
10. Methadone maintenance guidelines. The College of Physicians of Ontario, 2005
11. Satisfaction with treatment for attention-deficit/hyperactivity disorder. Bukstein OG, Am J Manag Care 2004 10 107 16 15352537
12. Measuring patient assessments of the quality of outpatient care: a systematic review. Saila T, Mattila E, Kaila M, Aalto P, Kaunonen M, J Eval Clin Pract 2008 14 148 54 10.1111/j.1365-2753.2007.00824.x 18211659
13. Patient satisfaction with mental health services: a meta-analysis to establish norms. Lehman AF, Zastowny TR, Eval Program Plann 1983 6 265 74 10.1016/0149-7189(83)90006-X 10267254
14. Patient satisfaction studies: methodology, management and consumer evaluation. Batchelor C, Owens DJ, Read M, Bloor M, Int J Health Care Qual Assur 1994 7 22 30 10.1108/09526869410074720 10140849
15. Patient assessment of treatment satisfaction: methods and practical issues. Revicki DA, Gut 2004 53 Suppl 4 40 4 iv
16. Issues in the measurement of satisfaction with treatment. Weaver M, Patrick DL, Markson LE, Martin D, Frederic I, Berger M, Am J Manag Care 1997 3 579 94 10169526 (Pubitemid 127528785)
17. Satisfaction guaranteed? What clients on methadone and buprenorphine think about their treatment. Madden A, Lea T, Bath N, Winstock AR, Drug Alcohol Rev 2008 27 671 8 10.1080/09595230801935706 19378450
18. A satisfaction survey of opioid-dependent clients at methadone treatment centres in Spain. Perez de los Cobos J, Fidel G, Escuder G, Haro G, Sanchez N, Pascual C, Valderrama JC, Valero S, Trujols J, Drug Alcohol Depend 2004 73 307 13 10.1016/j.drugalcdep.2003.11.001 15036553 (Pubitemid 38231042)
19. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment. Perez de Los Cobos J, Trujols J, Valderrama JC, Valero S, Puig T, Drug Alcohol Depend 2005 79 405 12 10.1016/j.drugalcdep.2005.03.021 15869846 (Pubitemid 41127170)
20. Patients prescribed injectable heroin or methadone -their opinions and experiences of treatment. Sell L, Zador D, Addiction 2004 99 442 9 10.1111/j.1360-0443.2003.00668.x 15049744 (Pubitemid 38496660)
21. A multicenter randomized evaluation of methadone medical maintenance. King VL, Stoller KB, Hayes M, Umbricht A, Currens M, Kidorf MS, Carter JA, Schwartz R, Brooner RK, Drug Alcohol Depend 2002 65 137 48 10.1016/S0376- 8716(01)00155-7 11772475 (Pubitemid 34084897)
22. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model. King VL, Kidorf MS, Stoller KB, Schwartz R, Kolodner K, Brooner RK, J Subst Abuse Treat 2006 31 385 93 10.1016/j.jsat.2006. 05.014 17084792 (Pubitemid 44648654)
23. Survey of client satisfaction with methadone maintenance programmes [abstract]. Kumar RM, Rajwal M, Psychiatric Bulletin 2006 16 18 (Pubitemid 43046212)
24. Consumer satisfaction with institutional and community care. Corrigan PW, Community Ment Health J 1990 26 151 65 10.1007/BF00752392 2191833 (Pubitemid 20239624)
25. Drug misuse treatment services in Scotland: predicting outcomes. Morris ZS, Gannon M, Int J Qual Health Care 2008 20 271 6 10.1093/intqhc/mzn019 18492708 (Pubitemid 352024910)
26. The Role of Patient Satisfaction in Methadone Treatment. Kelly SM, O'Grady KE, Brown BS, Mitchell SG, Schwartz RP, American Journal of Drug & Alcohol Abuse 2010 36 150 154 10.3109/00952991003736371 21796222
27. Patient Satisfaction and Sustained Outcomes of Drug Abuse Treatment. Zhiwei Zhang, Gerstein DR, Friedmann PD, Journal of Health Psychology 2008 13 388 400 10.1177/1359105307088142 18420772 (Pubitemid 351423170)
28. Patient satisfaction and outcomes in alcohol and drug abuse treatment. McLellan AT, Hunkeler E, Psychiatr Serv 1998 49 573 5 9603565 (Pubitemid 28208760)
29. Diacetylmorphine versus methadone for the treatment of opioid addiction. Oviedo-Joekes E, Brissette S, Marsh DC, Lauzon P, Guh D, Anis A, Schechter MT, N Engl J Med 2009 361 777 86 10.1056/NEJMoa0810635 19692689
30. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: Rationale and design of the NAOMI Study. Oviedo-Joekes E, Nosyk B, Marsh D, Guh D, Brissette S, Gartry C, Krausz M, Anis A, Schechter MT, Clinical Trials 2009 261 271
31. The North American Opiate Medication Initiative (NAOMI): Profile of Participants in North America's First Trial of Heroin-Assisted Treatment. Oviedo-Joekes E, Nosyk B, Brissette S, Chettiar J, Schneeberger P, Marsh DC, Krausz M, Anis A, Schechter MT, J Urban Health 2008 85 812 25 10.1007/s11524-008-9312-9 18758964
32. Potency ratio of hydromorphone and diacetylmorphine in substitution treatment for long-term opioid dependency. Oviedo-Joekes E, Marsh D, Guh D, Brissette S, Schechter MT, J Opioid Manag
33. Effectiveness of diacetylmorphine versus methadone for the treatment of opioid dependence in women. Oviedo-Joekes E, Guh D, Brissette S, Marchand K, Marsh D, Chettiar J, Nosyk B, Krausz M, Anis A, Schechter MT, Drug Alcohol Depend 2010
34. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. Kokkevi A, Hartgers C, Eur Addict Res 95 208 210
35. The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Marsden J, Gossop M, Stewart D, Best D, Farrell M, Lehmann P, Edwards C, Strang J, Addiction 1998 93 1857 67 10.1046/j.1360-0443.1998. 9312185711.x 9926574 (Pubitemid 28556612)
36. Assessment of client/patient satisfaction: development of a general scale. Larsen DL, Attkisson CC, Hargreaves WA, Nguyen TD, Eval Program Plann 1979 2 197 207 10.1016/0149-7189(79)90094-6 10245370 (Pubitemid 10119630)
37. Assessment of patient satisfaction: development and refinement of a service evaluation questionnaire. Nguyen TD, Attkisson CC, Stegner BL, Eval Program Plann 1983 6 299 313 10.1016/0149-7189(83)90010-1 10267258
38. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Atkinson MJ, Sinha A, Hass SL, Colman SS, Kumar RN, Brod M, Rowland CR, Health Qual Life Outcomes 2004 2 12 10.1186/1477-7525-2-12 14987333 (Pubitemid 39112018)
39. Patient satisfaction with an emergency department psychiatric service. O'Regan C, Ryan M, I Int J Health Care Qual Assur 2009 22 525 34 10.1108/09526860910975616
40. The Client Satisfaction Questionnaire: psychometric properties in a Dutch addict population. De Wilde EF, Hendriks VM, Eur Addict Res 2005 11 157 62 10.1159/000086396 16110221 (Pubitemid 41191609)
41. Predictors of retention in methadone programs: a signal detection analysis. Villafranca SW, McKellar JD, Trafton JA, Humphreys K, Drug Alcohol Depend 2006 83 218 24 10.1016/j.drugalcdep.2005.11.020 16384657 (Pubitemid 44202249)
42. Response to methadone maintenance treatment of opiate dependent patients with and without significant pain. Ilgen MA, Trafton JA, Humphreys K, Drug Alcohol Depend 2006 82 187 193 10.1016/j.drugalcdep.2005.09.005 16219429
43. Different Components of Opioid-Substitution Treatment Predict Outcomes of Patients With and Without a Parent With Substance-Use Problems. Trafton JA, Tracy SW, Oliva EM, Humphreys K, J Stud Alcohol Drugs 2007 68 165 172 17286334
44. Part C. The case of community methadone treatment programs. Ward J, World Health Organization (WHO), Evaluation of Psychoactive Substance Use Disorder Treatment: Workbook 6 Client Satisfaction Evaluations Geneva: World Health Organization 2000 32 38
45. Organization effects on client satisfaction with humaneness of service. Greenley JR, Schoenherr RA, J Health Soc Behav 1981 22 2 18 10.2307/2136364 7240704
46. Relationship between drug treatment services, retention, and outcomes. Hser YI, Evans E, Huang D, Anglin DM, Psychiatr Serv 2004 55 767 74 10.1176/appi.ps.55.7.767 15232015 (Pubitemid 38891229)
47. Acceptability, sensitivity and content validity of the VECS and VSSS in measuring expectations and satisfaction in psychiatric patients and their relatives. Ruggeri M, Dall'Agnola R, Agostini C, Bisoffi G, Soc Psychiatry Psychiatr Epidemiol 1994 29 265 76 10.1007/BF00802049 7825037 (Pubitemid 24350988)
48. Trajectories of heroin addiction: growth mixture modeling results based on a 33-year follow-up study. Hser YI, Huang D, Chou CP, Anglin MD, Eval Rev 2007 31 548 63 10.1177/0193841X07307315 17986707
49. The prisoner as patient-a health services satisfaction survey. Bjorngaard JH, Rustad AB, Kjelsberg E, BMC Health Serv Res 2009 9 176 10.1186/1472-6963-9- 176 19785736
50. Treatment needs and acknowledgement of illness-importance for satisfaction with psychiatric inpatient treatment. Soergaard KW, Nivison M, Hansen V, Oeiesvold T, BMC Health Serv Res 2008 8 103 10.1186/1472-6963-8-103 18479506 (Pubitemid 351725066)
51. Patient satisfaction: what we know about and what we still need to explore. Aharony L, Strasser S, Med Care Rev 1993 50 49 79 10.1177/ 002570879305000104 10125117
52. Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment. Oviedo-Joekes E, Guh D, Marsh DC, Brissette S, Nosyk B, Krausz M, Anis A, Christian WM, Spittal P, Schechter MT, Can J Public Health 2010 101 210 2 20737811
53. Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver. Callon C, Wood E, Marsh D, Li K, Montaner J, Kerr T, J Opioid Manag 2006 2 35 41 17319116
54. Joining the Circle, Phase II. Canadian Aboriginal AIDS Network, 2004
55. Client satisfaction with three therapies in the treatment of alcohol dependence: results from project MATCH. Donovan DM, Kadden RM, DiClemente CC, Carroll KM, Am J Addict 2002 11 291 307 10.1080/10550490290088090 12584872 (Pubitemid 35332506)
56. Patient satisfaction, use of services, and one-year outcomes in publicly funded substance abuse treatment. Carlson MJ, Gabriel RM, Psychiatr Serv 2001 52 1230 6 10.1176/appi.ps.52.9.1230 11533398 (Pubitemid 32823196)
57. Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study. Thomson CL, Morley KC, Teesson M, Sannibale C, Haber PS, Drug Alcohol Rev 2008 27 115 22 10.1080/09595230701829561 18264870
58. Barriers to Participation in Randomised Controlled Trials: A Systematic Review. Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R, J Clin Epidemiol 1999 52 1143 1156 10.1016/S0895-4356(99)00141-9 10580777 (Pubitemid 29535414)
59. Recruitment and retention of women for clinical leiomyoma trials. McCarthy-Keith D, Nurudeen S, Armstrong A, Levens E, Nieman LK, Contemp Clin Trials 2010 31 44 8 10.1016/j.cct.2009.09.007 19788933